Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
Katja Badanjak, Sonja Fixemer, Semra Smajić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4676-4676
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 116
Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
Ashley Payne, Samuel N. Nahashon, Equar Taka, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 371-371
Open Access | Times Cited: 109
Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model
Jingru Qiu, Ye Chen, Jing Zhuo, et al.
Neuropharmacology (2022) Vol. 207, pp. 108963-108963
Closed Access | Times Cited: 93
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Eveljn Scarian, Camilla Viola, Francesca Dragoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2698-2698
Open Access | Times Cited: 46
The immune system in Parkinson’s disease: what we know so far
Cintia Roodveldt, Liliana Bernardino, Özgür Öztop Çakmak, et al.
Brain (2024)
Open Access | Times Cited: 18
Free radicals and their impact on health and antioxidant defenses: a review
Nisansala Chandimali, Seon Gyeong Bak, Eun Hyun Park, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 175-175
Open Access | Times Cited: 56
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Giuseppe Arena, Karan Sharma, Gideon Agyeah, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 8, pp. 427-440
Open Access | Times Cited: 48
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14753-14753
Open Access | Times Cited: 44
Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson’s Disease Mouse Model
Zhengzheng Ruan, Dongdong Zhang, Ruixue Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2793-2793
Open Access | Times Cited: 43
Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes
Ruicheng Yang, Bo Yang, Wei Liu, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 37
The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 31
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Johanne Lauritsen, Marina Romero‐Ramos
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 863-878
Open Access | Times Cited: 31
Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-κB Signaling Pathway
Maria Magdalena Barreca, Riccardo Alessandro, Chiara Corrado
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9236-9236
Open Access | Times Cited: 29
Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
Saud A. Alnaaim, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 341-357
Open Access | Times Cited: 28
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 27
Microglia and Astroglia—The Potential Role in Neuroinflammation Induced by Pre- and Neonatal Exposure to Lead (Pb)
Magdalena Gąssowska-Dobrowolska, Mikołaj Chlubek, Agnieszka Kolasa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9903-9903
Open Access | Times Cited: 26
Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
Mohamed S. Attia, Ahmed Saeed Yahya, Nada Abdel Monaem, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 3, pp. 417-432
Open Access | Times Cited: 25
PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment
Xiaoyi Chen, Yunjiang Feng, Ronald J. Quinn, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 758-788
Open Access | Times Cited: 24
TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson’s Disease Mice and LPS-Induced BV2 Cells
Peiting Huang, Zhanyu Zhang, Piao Zhang, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2590-2605
Open Access | Times Cited: 24
Quantifying microglial morphology: an insight into function
Tabitha R. F. Green, Rachel K. Rowe
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 3, pp. 221-229
Open Access | Times Cited: 12
Neuroprotective effects of cordycepin on MPTP-induced Parkinson's disease mice via suppressing PI3K/AKT/mTOR and MAPK-mediated neuroinflammation
Linhai Wang, Shu Tian, Sisi Ruan, et al.
Free Radical Biology and Medicine (2024) Vol. 216, pp. 60-77
Closed Access | Times Cited: 12
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder
Shilu Deepa Thomas, Sabna Abdalla, Nermin Eissa, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 831-831
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top